[go: up one dir, main page]

ZA200901124B - Quinuclidine derivatives as M3 antagonists - Google Patents

Quinuclidine derivatives as M3 antagonists

Info

Publication number
ZA200901124B
ZA200901124B ZA200901124A ZA200901124A ZA200901124B ZA 200901124 B ZA200901124 B ZA 200901124B ZA 200901124 A ZA200901124 A ZA 200901124A ZA 200901124 A ZA200901124 A ZA 200901124A ZA 200901124 B ZA200901124 B ZA 200901124B
Authority
ZA
South Africa
Prior art keywords
antagonists
quinuclidine derivatives
quinuclidine
derivatives
Prior art date
Application number
ZA200901124A
Other languages
English (en)
Inventor
Gabriele Amari
Andrea Rizzi
Riccardo Patacchini
Valentina Cenacchi
Gino Villetti
Ruiz Juan Lorenzo Catena
Masip Isabel Masip
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ZA200901124B publication Critical patent/ZA200901124B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200901124A 2006-07-26 2007-07-23 Quinuclidine derivatives as M3 antagonists ZA200901124B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06117883A EP1882691A1 (en) 2006-07-26 2006-07-26 Quinuclidine derivatives as M3 antagonists

Publications (1)

Publication Number Publication Date
ZA200901124B true ZA200901124B (en) 2010-05-26

Family

ID=37890216

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200901124A ZA200901124B (en) 2006-07-26 2007-07-23 Quinuclidine derivatives as M3 antagonists

Country Status (16)

Country Link
US (1) US7838534B2 (zh)
EP (2) EP1882691A1 (zh)
JP (1) JP5331688B2 (zh)
KR (1) KR20090033443A (zh)
CN (1) CN101490049A (zh)
AR (1) AR062104A1 (zh)
AU (1) AU2007278231B2 (zh)
BR (1) BRPI0713826A2 (zh)
CA (1) CA2658649A1 (zh)
CL (1) CL2007002159A1 (zh)
EA (1) EA017698B1 (zh)
MX (1) MX2009000999A (zh)
PE (1) PE20080407A1 (zh)
TW (1) TW200817398A (zh)
WO (1) WO2008012290A2 (zh)
ZA (1) ZA200901124B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL362989A1 (en) 2000-12-22 2004-11-15 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
ES2246170B1 (es) * 2004-07-29 2007-04-01 Almirall Prodesfarma, S.A. Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.
EP2080508A1 (en) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Dry powder formulation comprising an anticholinergic drug
EP2080507A1 (en) * 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Pharmaceutical formulations comprising an anticholinergic drug
EP2080523A1 (en) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Compositions comprising an antimuscarinic and a long-acting beta-agonist
EP2154136A1 (en) 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Quinuclidine carbonate derivatives and medicinal compositions thereof
EP2206712A1 (en) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
NZ604983A (en) * 2010-06-22 2014-07-25 Chiesi Farma Spa Dry powder formulation comprising an antimuscarinic drug
BR112012032332A2 (pt) 2010-06-22 2016-11-08 Chiesi Farma Spa composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo
CA2803433A1 (en) 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Alkaloid aminoester derivatives and medicinal composition thereof
RU2569846C2 (ru) 2010-06-22 2015-11-27 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Алкалоидные производные сложных аминоэфиров и включающие их лекарственные композиции
EP2643295B1 (en) 2010-11-26 2016-04-13 Chiesi Farmaceutici S.p.A. Glycine derivatives and their use as muscarinic receptor antagonists
US20120220557A1 (en) 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug
CA2834467A1 (en) 2011-04-29 2012-11-01 Chiesi Farmaceutici S.P.A. Alkaloid ester and carbamate derivatives and medicinal compositions thereof
CA2862008A1 (en) 2011-12-30 2013-07-04 Chiesi Farmaceutici S.P.A. Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001266100B9 (en) 2000-06-27 2005-10-06 Laboratorios S.A.L.V.A.T., S.A. Carbamates derived from arylalkylamines
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
PL362989A1 (en) * 2000-12-22 2004-11-15 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
RS52522B (sr) * 2001-12-20 2013-04-30 Chiesi Farmaceutici S.P.A. Derivati 1-alkil-1-azoniabiciklo/2.2.2./oktan karbamata i njihova upotreba kao antagonista muskarinskih receptora
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
EA200970158A1 (ru) 2009-06-30
WO2008012290A3 (en) 2008-03-13
TW200817398A (en) 2008-04-16
AR062104A1 (es) 2008-10-15
EA017698B1 (ru) 2013-02-28
AU2007278231A1 (en) 2008-01-31
PE20080407A1 (es) 2008-06-17
CA2658649A1 (en) 2008-01-31
AU2007278231B2 (en) 2012-08-16
US7838534B2 (en) 2010-11-23
JP2009544659A (ja) 2009-12-17
EP2049533A2 (en) 2009-04-22
US20080039493A1 (en) 2008-02-14
EP1882691A1 (en) 2008-01-30
CN101490049A (zh) 2009-07-22
MX2009000999A (es) 2009-04-15
KR20090033443A (ko) 2009-04-03
JP5331688B2 (ja) 2013-10-30
CL2007002159A1 (es) 2008-01-04
WO2008012290A2 (en) 2008-01-31
BRPI0713826A2 (pt) 2015-05-12

Similar Documents

Publication Publication Date Title
ZA200901124B (en) Quinuclidine derivatives as M3 antagonists
HUS1900033I1 (hu) Szubsztituált enaminokarbonil vegyületek
IL195010A0 (en) Bicyclic derivatives as cetp inhibitors
ZA200806809B (en) Pyridine-2-carboxamide derivatives
ZA200708028B (en) Acetylenyl-pyrazolo-pyrimidine derivatives as mGluR2 antagonists
IL194583A0 (en) Imidazo compounds
ZA200906812B (en) Crig antagonists
IL199015A0 (en) Quinuclidinol derivatives as muscarinic receptor antagonists
SI2069310T1 (sl) Sulfonilpirazolin-1-karboksamidinski derivati kot 5-HT6 antagonisti
IL192799A0 (en) Substituted 4-phenylpiperidines
IL206402A0 (en) Bicyclic heterocyclic derivative
IL199971A0 (en) Heterocyclic derivatives as m3 muscarinic receptors
ZA201007988B (en) Quinuclidine derivatives as muscarinic m3 receptor antagonists
IL202339A0 (en) Azacyclylbenzamide derivatives as histamine-3 antagonists
IL195027A0 (en) Constrained compounds as cgrp-receptor antagonists
ZA200809205B (en) Constrained compounds as CGRP-receptor antagonists
ZA200903523B (en) Poly-TLR antagonist
ZA200903382B (en) Substituted 4-imidazoles
ZA200901570B (en) Substituted azolin-2-YL-amino compounds
HK1155157A (zh) 作用为毒蕈碱m3受体拮抗剂的奎宁环衍生物
GB0724654D0 (en) Prolactin antagonist
PL384071A1 (pl) Konik obrabiarki
PL384072A1 (pl) Konik obrabiarki
GB0610018D0 (en) Benzotriazepinone derivatives
GB0610019D0 (en) Benzotriazepinone derivatives